The trypanolytic factor of human serum, Nat Rev Microbiol, vol.4, pp.477-86, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00552632
Association of trypanolytic ApoL1 variants with kidney disease in African Americans, Science, vol.329, pp.841-846, 2010. ,
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy, J Am Soc Nephrol, vol.22, pp.2129-2166, 2011. ,
DOI : 10.1681/asn.2011040388
URL : https://jasn.asnjournals.org/content/22/11/2129.full.pdf
APOL1 toxin, innate immunity, and kidney injury, Kidney Int, vol.88, pp.28-34, 2015. ,
DOI : 10.1038/ki.2015.109
URL : http://europepmc.org/articles/pmc4490079?pdf=render
APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans, J Am Soc Nephrol, vol.26, pp.2882-90, 2015. ,
DOI : 10.1681/asn.2014050469
URL : https://jasn.asnjournals.org/content/26/11/2882.full.pdf
Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients, Am J kidney Dis, vol.35, pp.884-892, 2000. ,
Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study, AIDS, vol.18, pp.541-547, 2004. ,
HIV compromises integrity of the podocyte actin cytoskeleton through downregulation of the vitamin D receptor, Am J Physiol Renal Physiol, vol.304, pp.1347-57, 2013. ,
HIV-1 and interferons: who's interfering with whom?, Nat Rev Microbiol, vol.13, pp.403-416, 2015. ,
DOI : 10.1038/nrmicro3449
APOL1 renal risk variants: fertile soil for hiv-associated nephropathy, Semin Nephrol, vol.37, pp.514-523, 2017. ,
DOI : 10.1016/j.semnephrol.2017.07.004
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745063
Impact of APOL1 polymorphism and IL-1beta priming in the entry and persistence of HIV-1 in human podocytes, Retrovirology, vol.13, p.63, 2016. ,
The innate immune factor apolipoprotein L1 restricts HIV-1 infection, J Virol, vol.88, pp.592-603, 2014. ,
DOI : 10.1128/jvi.02828-13
URL : http://europepmc.org/articles/pmc3911732?pdf=render
APOL1 kidney risk alleles: population genetics and disease associations, Adv Chronic Kidney Dis, vol.21, pp.426-459, 2014. ,
DOI : 10.1053/j.ackd.2014.06.005
URL : http://europepmc.org/articles/pmc4157456?pdf=render
Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count, JAMA, vol.279, pp.35-40, 1998. ,
Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals, PLoS Genet, vol.3, p.19, 2007. ,
Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations, Am J Hum Genet, vol.93, pp.54-66, 2013. ,
APOL1-mediated cell injury involves disruption of conserved trafficking processes, J Am Soc Nephrol, vol.28, 2017. ,
The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status, Clin Infect Dis, vol.60, pp.646-52, 2015. ,
Common genetic variation and the control of HIV-1 in humans, PLoS Genet, vol.5, p.1000791, 2009. ,
, Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome, MMWR, pp.1-15, 1987.
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users, AIDS, vol.15, pp.1707-1722, 2001. ,
Human genes that limit AIDS, Nat Genet, vol.36, pp.565-74, 2004. ,
Macrophages and HIV-1: an unhealthy constellation, Cell Host Microbe, vol.19, pp.304-314, 2016. ,
DOI : 10.1016/j.chom.2016.02.013
URL : https://doi.org/10.1016/j.chom.2016.02.013
Macrophages and their relevance in Human Immunodeficiency Virus Type I infection, Retrovirology, vol.9, p.82, 2012. ,
APOL1 genotype and glomerular and tubular kidney injury in women with HIV, Am J Kid Dis, vol.65, pp.889-98, 2015. ,
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference, Kidney Int, vol.93, pp.545-59, 2018. ,